Acetyl-11-keto-β-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy

Experimental Eye Research

Volumn 135, Issue , 2015, Pages 67-80

  Lulli, Matteo ^a   Cammalleri, Maurizio ^b   Fornaciari, Irene ^b   Casini, Giovanni ^b   Dal Monte, Massimo ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

CD31 Immunohistochemistry; Cytochrome c; Electroretinogram; HRMECs; SHP 1; STAT3; VEGF

Indexed keywords

11 OXO BETA BOSWELLIC ACID; PROTEIN TYROSINE PHOSPHATASE SHP 1; STAT3 PROTEIN; TRANSCRIPTION FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; ACETYL-11-KETOBOSWELLIC ACID; ANGIOGENESIS INHIBITOR; PTPN6 PROTEIN, MOUSE; TRITERPENE; VASCULOTROPIN A; VEGFR2 PROTEIN, MOUSE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVITY; EXPLANT; FEMALE; HYPOXIA; MALE; MOUSE; NONHUMAN; OXYGEN-INDUCED RETINOPATHY; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RETINA; RETINA CELL; RETINA NEOVASCULARIZATION; ANIMAL; APOPTOSIS; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; ELECTRORETINOGRAPHY; METABOLISM; PATHOPHYSIOLOGY; RETINAL NEOVASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; ENDOTHELIAL CELLS; FEMALE; MALE; MICE; MICE, INBRED C57BL; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; RETINAL NEOVASCULARIZATION; TRITERPENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84928715673     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2015.04.011     Document Type: Article

References (57)

1. Augustin A.J., Puls S., Offermann I. Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone. Retina 2007, 27:133-140.
2. Bai Y., Ma J.X., Guo J., Wang J., Zhu M., Chen Y., Le Y.Z. Müller cell-derived VEGF is a significant contributor to retinal neovascularization. J.Pathol. 2009, 219:446-454.
3. Bhat T.A., Nambiar D., Tailor D., Pal A., Agarwal R., Singh R.P. Acacetin inhibits invitro and invivo angiogenesis and downregulates stat signaling and VEGF expression. Cancer Prev. Res. 2013, 6:1128-1139.
4. Bresnick G.H., Palta M. Oscillatory potential amplitudes. Relation to severity of diabetic retinopathy. Arch. Ophthalmol. 1987, 105:929-933.
5. Casini G., Dal Monte M., Fornaciari I., Filippi L., Bagnoli P. The β-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases. Prog. Retin. Eye Res. 2014, 42:103-129.
6. Cervia D., Catalani E., Dal Monte M., Casini G. Vascular endothelial growth factor in the ischemic retina and its regulation by somatostatin. J.Neurochem. 2012, 120:818-829.
7. Chen Z., Han Z.C. STAT3: a critical transcription activator in angiogenesis. Med. Res. Rev. 2008, 28:185-200.
8. Chen Z., Liu G., Xiao Y., Lu P. Adrenomedullin22-52 suppresses high-glucose-induced migration, proliferation, and tube formation of human retinal endothelial cells. Mol. Vis. 2014, 20:259-269.
9. Chu L.Y., Ramakrishnan D.P., Silverstein R.L. Thrombospondin-1 modulates VEGF signaling via CD36 by recruiting SHP-1 to VEGFR-2 complex in microvascular endothelial cells. Blood 2013, 122:1822-1832.
10. Dal Monte M., Casini G., la Marca G., Isacchi B., Filippi L., Bagnoli P. Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice. Exp. Eye Res. 2013, 111:27-35.
11. Dal Monte M., Landi D., Martini D., Bagnoli P. Antiangiogenic role of miR-361 in human umbilical vein endothelial cells: functional interaction with the peptide somatostatin. Naunyn Schmiedeb. Arch. Pharmacol. 2013, 386:15-27.
12. Dal Monte M., Latina V., Cupisti E., Bagnoli P. Protective role of somatostatin receptor 2 against retinal degeneration in response to hypoxia. Naunyn Schmiedeb. Arch. Pharmacol. 2012, 385:481-494.
13. Dal Monte M., Martini D., Latina V., Pavan B., Filippi L., Bagnoli P. Beta-adrenoreceptor (β-AR) agonism influences retinal responses to hypoxia in a mouse model of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 2012, 53:2181-2192.
14. Dal Monte M., Martini D., Ristori C., Azara D., Armani C., Balbarini A., Bagnoli P. Hypoxia effects on proangiogenic factors in human umbilical vein endothelial cells: functional role of the peptide somatostatin. Naunyn Schmiedeb. Arch. Pharmacol. 2011, 383:593-612.
15. Dal Monte M., Ristori C., Videau C., Loudes C., Martini D., Casini G., Epelbaum J., Bagnoli P. Expression, localization, and functional coupling of the somatostatin receptor subtype 2 in a mouse model of oxygen-induced retinopathy. Invest. Ophthalmol. Vis. Sci. 2010, 51:1848-1856.
16. Doucette T.A., Kong L.Y., Yang Y., Ferguson S.D., Yang J., Wei J., Qiao W., Fuller G.N., Bhat K.P., Aldape K., Priebe W., Bögler O., Heimberger A.B., Rao G. Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma. Neuro Oncol. 2012, 14:1136-1145.
17. Du G., Zhu H., Yu P., Wang H., He J., Ye L., Fu F., Zhang J., Tian J. SMND-309 promotes angiogenesis in human umbilical vein endothelial cells through activating erythropoietin receptor/STAT3/VEGF pathways. Eur. J. Pharmacol. 2013, 700:173-180.
18. Favaloro E.J., Moraitis N., Koutts J., Exner T., Bradstock K.F. Endothelial cells and normal circulating haemopoietic cells share a number of surface antigens. Thromb. Haemost. 1989, 61:217-224.
19. Gariano R.F., Gardner T.W. Retinal angiogenesis in development and disease. Nature 2005, 438:960-966.
20. Gerhardt H., Seifert F., Buvari P., Vogelsang H., Repges R. Therapy of active Crohn disease with Boswellia serrata extract H 15. Z.Gastroenterol. 2001, 39:11-17.
21. Hatzopoulos K.M., Vessey K.A., Wilkinson-Berka J.L., Fletcher E.L. The vasoneuronal effects of AT1 receptor blockade in a rat model of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 2014, 55:3957-3970.
22. Ji J.Z., Elyaman W., Yip H.K., Lee V.W., Yick L.W., Hugon J., So K.F. CNTF promotes survival of retinal ganglion cells after induction of ocular hypertension in rats: the possible involvement of STAT3 pathway. Eur. J. Neurosci. 2004, 19:265-272.
23. Kinnunen K., Ylä-Herttuala S. Vascular endothelial growth factors in retinal and choroidal neovascular diseases. Ann. Med. 2012, 44:1-17.
24. Klein J.D., Sano D., Sen M., Myers J.N., Grandis J.R., Kim S. STAT3 oligonucleotide inhibits tumor angiogenesis in preclinical models of squamous cell carcinoma. PLoS One 2014, 9:e81819.
25. Krüger P., Kanzer J., Hummel J., Fricker G., Schubert-Zsilavecz M., Abdel-Tawab M. Permeation of Boswellia extract in the Caco-2 model and possible interactions of its constituents KBA and AKBA with OATP1B3 and MRP2. Eur. J. Pharm. Sci. 2009, 36:275-284.
26. Kunnumakkara A.B., Nair A.S., Sung B., Pandey M.K., Aggarwal B.B. Boswellic acid blocks signal transducers and activators of transcription 3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase SHP-1. Mol. Cancer Res. 2009, 7:118-128.
27. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(_Delta Delta C(T)) Method. Methods 2001, 25:402-408.
28. Lyons B.L., Smith R.S., Hurd R.E., Hawes N.L., Burzenski L.M., Nusinowitz S., Hasham M.G., Chang B., Shultz L.D. Deficiency of SHP-1 protein-tyrosine phosphatase in "viable motheaten" mice results in retinal degeneration. Invest. Ophthalmol. Vis. Sci. 2006, 47:1201-1209.
29. Martini D., Dal Monte M., Ristori C., Cupisti E., Mei S., Fiorini P., Filippi L., Bagnoli P. Antiangiogenic effects of β2 -adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy. J.Neurochem. 2011, 119:1317-1329.
30. Mazumder B., Sampath P., Seshadri V., Maitra R.K., DiCorleto P.E., Fox P.L. Regulated release of L13a from the 60S ribosomal subunit as a mechanism of transcript-specific translational control. Cell 2003, 115:187-198.
31. Mechoulam H., Pierce E.A. Expression and activation of STAT3 in ischemia-induced retinopathy. Invest. Ophthalmol. Vis. Sci. 2005, 46:4409-4416.
32. Mei S., Cammalleri M., Azara D., Casini G., Bagnoli P., Dal Monte M. Mechanisms underlying somatostatin receptor 2 down-regulation of vascular endothelial growth factor expression in response to hypoxia in mouse retinal explants. J.Pathol. 2012, 226:519-533.
33. Miller J.W., Le Couter J., Strauss E.C., Ferrara N. Vascular endothelial growth factor a in intraocular vascular disease. Ophthalmology 2013, 120:106-114.
34. Pang X., Yi Z., Zhang X., Sung B., Qu W., Lian X., Aggarwal B.B., Liu M. Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. Cancer Res. 2009, 69:5893-5900.
35. Pang X., Yi T., Yi Z., Cho S.G., Qu W., Pinkaew D., Fujise K., Liu M. Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways. Cancer Res. 2009, 69:518-525.
36. Park B., Sung B., Yadav V.R., Cho S.G., Liu M., Aggarwal B.B. Acetyl-11-keto-β-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression. Int. J. Cancer 2011, 129:23-33.
37. Park B., Prasad S., Yadav V., Sung B., Aggarwal B.B. Boswellic acid suppresses growth and metastasis of human pancreatic tumors in an orthotopic nude mouse model through modulation of multiple targets. PLoS One 2011, 6:e26943.
38. Pattyn F., Speleman F., De Paepe A., Vandesompele J. RT Primer DB: the real-time PCR primer and probe database. Nucleic Acids Res. 2003, 31:122-123.
39. Ristori C., Filippi L., Dal Monte M., Martini D., Cammalleri M., Fortunato P., la Marca G., Fiorini P., Bagnoli P. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade. Invest. Ophthalmol. Vis. Sci. 2011, 52:155-170.
40. Robson J.G., Saszik S.M., Ahmed J., Frishman L.J. Rod and cone contributions to the a-wave of the electroretinogram of the macaque. J.Physiol. 2003, 547:509-530.
41. Sengupta K., Alluri K.V., Satish A.R., Mishra S., Golakoti T., Sarma K.V., Dey D., Raychaudhuri S.P. Adouble blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Res. Ther. 2008, 10:R85.
42. Singh S.K., Bhusari S., Singh R., Saxena A., Mondhe D., Qazi G.N. Effect of acetyl 11-keto beta-boswellic acid on metastatic growth factor responsible for angiogenesis. Vasc. Pharmacol. 2007, 46:333-337.
43. Smith L.E., Wesolowski E., McLellan A., Kostyk S.K., D'Amato R., Sullivan R., D'Amore P.A. Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 1994, 35:101-111.
44. Song M.K., Roufogalis B.D., Huang T.H. Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ-related pharmacology. Br. J. Pharmacol. 2012, 165:4-19.
45. Takada Y., Ichikawa H., Badmaev V., Aggarwal B.B. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression. J.Immunol. 2006, 176:3127-3140.
46. Takahashi M., Sung B., Shen Y., Hur K., Link A., Boland C.R., Aggarwal B.B., Goel A. Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and miR-200 microRNA family. Carcinogenesis 2012, 33:2441-2449.
47. Vessey K.A., Wilkinson-Berka J.L., Fletcher E.L. Characterization of retinal function and glial cell response in a mouse model of oxygen induced retinopathy. J.Comp. Neurol. 2011, 519:506-527.
48. Wang H., Byfield G., Jiang Y., Smith G.W., McCloskey M., Hartnett M.E. VEGF-mediated STAT3 activation inhibits retinal vascularization by down-regulating local erythropoietin expression. Am. J. Pathol. 2012, 180:1243-1253.
49. Wang X., Seed B. APCR primer bank for quantitative gene expression analysis. Nucleic Acids Res. 2003, 31:e154.
50. Weidemann A., Krohne T.U., Aguilar E., Kurihara T., Takeda N., Dorrell M.I., Simon M.C., Haase V.H., Friedlander M., Johnson R.S. Astrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retina. Glia 2010, 58:1177-1185.
51. Witmer A.N., Vrensen G.F., Van Noorden C.J., Schlingemann R.O. Vascular endothelial growth factors and angiogenesis in eye disease. Prog. Retin. Eye Res. 2003, 22:1-29.
52. Yadav V.R., Prasad S., Sung B., Gelovani J.G., Guha S., Krishnan S., Aggarwal B.B. Boswellic acid inhibits growth and metastasis of human colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive and angiogenic biomarkers. Int. J. Cancer 2012, 130:2176-2184.
53. Yadav U.C., Srivastava S.K., Ramana K.V. Prevention of VEGF-induced growth and tube formation in human retinal endothelial cells by aldose reductase inhibition. J.Diabetes Complicat. 2012, 26:369-377.
54. Yafai Y., Iandiev I., Wiedemann P., Reichenbach A., Eichler W. Retinal endothelial angiogenic activity: effects of hypoxia and glial (Müller) cells. Microcirculation 2004, 11:577-586.
55. Yanni S.E., McCollum G.W., Penn J.S. Genetic deletion of COX-2 diminishes VEGF production in mouse retinal Müller cells. Exp. Eye Res. 2010, 91:34-41.
56. Yuan Y., Cui S.X., Wang Y., Ke H.N., Wang R.Q., Lou H.X., Gao Z.H., Qu X.J. Acetyl-11-keto-beta-boswellic acid (AKBA) prevents human colonic adenocarcinoma growth through modulation of multiple signaling pathways. Biochim. Biophys. Acta 2013, 1830:4907-4916.
57. Zhang Y.S., Xie J.Z., Zhong J.L., Li Y.Y., Wang R.Q., Qin Y.Z., Lou H.X., Gao Z.H., Qu X.J. Acetyl-11-keto-β-boswellic acid (AKBA) inhibits human gastric carcinoma growth through modulation of the Wnt/β-catenin signaling pathway. Biochim. Biophys. Acta 2013, 1830:3604-3615.